FDA approves ADHD med Intuniv

(Reuters) UPDATED 2009-09-09

The U.S. Food and Drug Administration has approved the extended-release ADHD drug Intuniv. Intuniv will be the first selective alpha-2A receptor agonist approved for the treatment of ADHD. The drug is approved for children ages 6 to 17, and should be available from pharmacies beginning in November 2009. Read full story >

See all ADHD News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA approves ADHD med Intuniv

People who read this also read...

What the community is saying...

Blood Pressure Medication to Treat ADHD

Eileen Bailey